MiniMed (MMED) Other Accumulated Expenses (2025 - 2026)

MiniMed (MMED) posted Other Accumulated Expenses of $137.0 million for Q2 2026, down 14.91% on a QoQ basis from $161.0 million in Q1 2026, and down 49.45% year-over-year from $271.0 million in Q2 2025.

MiniMed (MMED) Other Accumulated Expenses (2025 - 2026) Analysis & Trends

MiniMed's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $137.0 million for Q2 2026.

  • Quarterly Other Accumulated Expenses fell 49.45% year-over-year to $137.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $137.0 million (down 49.45% YoY) and the FY2026 annual result came in at $137.0 million, down 49.45% from the prior year.
  • Other Accumulated Expenses was $137.0 million for Q2 2026 at MiniMed, down from $161.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $271.0 million in Q2 2025 and bottomed at $137.0 million in Q2 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 32.17 Bn 24.85 Bn 662.02 Mn
2 BrightSpring Health Services 14.60 Bn 13.70 Bn 482.22 Mn
3 Healthequity 8.41 Bn 8.14 Bn 256.31 Mn
4 Hinge Health 5.96 Bn 5.64 Bn 154.23 Mn
5 10x Genomics 5.86 Bn 5.32 Bn 106.18 Mn
6 MiniMed 4.51 Bn 4.21 Bn 480.00 Mn
7 Waystar Holding 4.47 Bn 4.40 Bn 216.84 Mn
8 Doximity 3.95 Bn 3.21 Bn 125.97 Mn
9 Privia Health 3.12 Bn 2.70 Bn -
10 Omnicell 1.88 Bn 1.64 Bn 140.36 Mn

Historic Data

Download Data
DateValue
Apr 24, 2026 137.00 Mn
Jan 23, 2026 161.00 Mn
Apr 25, 2025 271.00 Mn